Search

everythinglearnresearchcommunity

for

Search:↓

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

The genes KRT25 and SP6 affect curly hair in horses, with KRT25 also causing hair loss. If both genes are mutated, the horse gets curly hair and hair loss. KRT25 can hide the effect of SP6.

Human hair keratins K85 and K35 create unique filament patterns important for early hair formation.

More research is needed to understand how testosterone is maintained in adult males.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

KRT85 gene variations can help improve wool traits in sheep through selective breeding.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Keratin proteins are increasingly recognized as important for cell health and are linked to many diseases.

Hair growth and development are controlled by specific signaling pathways.

Targeting the Smoothened receptor shows promise for treating certain cancers.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Desmoglein 4 is controlled by specific proteins that affect hair growth.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Genetic variation in the KRTAP15-1 gene affects wool yield in sheep.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

A new therapy for a skin blistering condition has not been developed yet.